Skip to main content
Livermore
Livermore
ZHEN

Core Alternative Capital

SEC CIK
0001776878
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Core Alternative Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
2,784
Value
$252.6K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Core Alternative Capital, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,784$252.6K0.1%+464+20.0%AddedHolders
Q1 20262,320$238.2K0.1%+416+21.8%AddedHolders
Q4 20251,904$238.6K0.1%+1,848+3,300.0%AddedHolders
Q3 202556$7.50K<0.1%00.0%UnchangedHolders
Q2 202556$7.62K<0.1%00.0%UnchangedHolders
Q1 202556$7.43K<0.1%−547−90.7%ReducedHolders
Q4 2024603$68.2K<0.1%+47+8.5%AddedHolders
Q3 2024556$63.4K<0.1%00.0%UnchangedHolders
Q2 2024556$57.8K<0.1%00.0%UnchangedHolders
Q1 2024556$63.2K<0.1%−657−54.2%ReducedHolders
Q4 20231,213$133.5K<0.1%−126−9.4%ReducedHolders
Q3 20231,339$129.6K<0.1%+49+3.8%AddedHolders
Q2 20231,290$140.7K<0.1%+274+27.0%AddedHolders
Q1 20231,016$102.9K<0.1%+376+58.8%AddedHolders
Q4 2022640$70.3K<0.1%−971−60.3%ReducedHolders
Q3 20221,611$156.0K<0.1%−455−22.0%ReducedHolders
Q2 20222,066$224.0K0.1%+135+7.0%AddedHolders
Q1 20221,931$229.0K0.1%−24,027−92.6%ReducedHolders
Q4 202125,958$3.65M0.7%−3,879−13.0%ReducedHolders
Q3 202129,837$3.52M0.7%−1,193−3.8%ReducedHolders
Q2 202131,030$3.60M0.8%+8,236+36.1%AddedHolders
Q1 202122,794$2.73M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.